Cardiolyse ECG Workspace puts editable AI findings before clinician sign-off

Cardiolyse launched ECG Workspace on October 29, bringing automated analysis of 12‑lead resting ECGs and clinician review into the same browser environment. The company’s announcement describes recordings arriving with automated measurements and proposed findings, followed by a clinician examining the recording, changing measurements or interpretation, and approving and signing the final report.

The distinction matters for a team choosing clinical software: receiving an algorithm’s proposed interpretation and completing a signed review are different steps. The announced workspace puts the underlying recording and the tools to revise that proposal into the same workflow. It does not describe AI output as the final signed report.

In the workflow Cardiolyse describes, clinicians can inspect all 12 leads and use on‑screen tools to measure the waveforms. Proposed findings appear beside the original recording and remain editable before approval. A reviewer can therefore examine the evidence and change the interpretation within the workspace, rather than treating the first read as a finished document. [Source: Cardiolyse](https://www.globenewswire.com/news‑release/2026/10/29/3390924/0/en/cardiolyse‑launches‑ai‑powered‑ecg‑workspace‑for‑12‑lead‑ecg‑review‑from‑first‑read‑to‑clinician‑sign‑off.html) The company’s [product page](https://cardiolyse.com/cardiolyse‑ecg‑workspace) adds that automatically measured values are marked as automatic and can be corrected. It also says edits and sign‑offs are recorded in an audit trail, preserving what the AI proposed and what the reader confirmed. That is a different product requirement from generating findings: the service must also keep track of the review that turns a proposal into a signed result.

The release describes a central worklist that collects incoming cases and displays their review status. Cardiolyse positions it for hospitals, clinics and remote ECG reading services handling recordings from connected sites and devices. [Source: launch announcement](https://www.globenewswire.com/news‑release/2026/10/29/3390924/0/en/cardiolyse‑launches‑ai‑powered‑ecg‑workspace‑for‑12‑lead‑ecg‑review‑from‑first‑read‑to‑clinician‑sign‑off.html) This gives the product two connected jobs. The reading screen is where a clinician examines and edits an individual ECG; the worklist is where a team sees the cases and their progress. A demonstration for a reading service should show the handoff between those views as well as the final report. The announcement does not establish that every device or existing hospital system will connect without integration work.

For a team evaluating the workspace, the useful walkthrough runs from the incoming recording to its proposed findings, the reviewer’s changes and the signed result. It should make clear which values came from automated analysis, which were changed and how the case’s status reflects completion. Those are questions about the announced workflow, rather than evidence that the software improves diagnoses or patient outcomes.

Cardiolyse says its ECG analytics are CE‑marked as a Class IIa medical device. That regulatory description is the company’s statement in the release; regulatory documents were not independently reviewed for this report. The launch establishes a new review environment and its described controls, not an independently verified accuracy comparison.

Archival photograph of an ECG recording at a health check‑up camp in Howrah, India, on April 12, 2015; it does not show Cardiolyse software. Photo: Biswarup Ganguly / Wikimedia Commons, CC BY 3.0; cropped and downsampled.